IL-22BP/IL22 RA2 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NB100-742
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat
Cited:
Human
Applications
Validated:
ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin
Cited:
IF/IHC
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Format
BSA Free
Concentration
1.0 mg/ml
Product Specifications
Immunogen
Synthetic peptide RVQFQSRNFHNILQWQPGRALTGNSSVY-C corresponding to 33-60 residues of N-terminus of human IL-22R-alpha-2 protein with cysteine added for conjugation to a carrier protein.
Localization
Secreted
Specificity
IL22 RA2
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for IL-22BP/IL22 RA2 Antibody - BSA Free
Immunohistochemistry-Paraffin: IL-22BP/IL22 RA2 Antibody - BSA Free [NB100-742]
Immunohistochemistry-Paraffin: IL-22BP/IL22 RA2 Antibody [NB100-742] - Paraffin section of human spleen.Applications for IL-22BP/IL22 RA2 Antibody - BSA Free
Application
Recommended Usage
ELISA
1:50000
Immunohistochemistry
1:150
Immunohistochemistry-Paraffin
1:150
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
10mM KHPO4 and 0.14M NaCl, pH 7.2
Format
BSA Free
Preservative
0.1% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: IL-22BP
Long Name
Interleukin 22 Binding Protein
Alternate Names
CRF2-10, CRF2-X, IL-22 RA2, IL22BP, IL22RA2
Entrez Gene IDs
116379 (Human)
Gene Symbol
IL22RA2
UniProt
Additional IL-22BP Products
Product Documents for IL-22BP/IL22 RA2 Antibody - BSA Free
Product Specific Notices for IL-22BP/IL22 RA2 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...